MARGARET SEEDORF: Open Payments
NPI 1114030202 · PITTSBURG, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 51 payments from 31 companies in 2025. Trend: 2023 $664 · 2024 $905 · 2025 $1,329
Food & beverage: $1,329
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $133 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| ABBVIE INC. | 3 | $92 |
| Janssen Biotech, Inc. | 4 | $80 |
| PFIZER INC. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Incyte Corporation | 3 | $54 |
| Eisai Inc. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $47 |
Products named: DATROWAY, KISQALI, ENHERTU, XYNTHA, LIBTAYO, Lenvima, NINLARO, RYBREVANT.
Industry payments across KS — which companies pay providers there.
